Interleukin-6 (IL-6) has been proven to be a significant nonmatrix target of MMPs in cancer growth and development by modulating many signaling molecules, in particular signal transducer and activator of transcription-3 (STAT-3) and extracellular signal-regulated kinase (ERK) 1/2. This evidence concerns the gene STAT3 and cancer.